Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemia

被引：31
作者：
Gassner, Franz J. [1 ]
Zaborsky, Nadja [1 ]
Neureiter, Daniel [2 ]
Huemer, Michael [1 ]
Melchardt, Thomas [1 ]
Egle, Alexander [1 ]
Rebhandl, Stefan [1 ]
Catakovic, Kemal [1 ]
Hartmann, Tanja N. [1 ]
Greil, Richard [1 ]
Geisberger, Roland [1 ]
机构：
[1] Paracelsus Med Univ Salzburg, Lab Immunol & Mol Canc Res, Ctr Oncol, Dept Internal Med Hematol Med Oncol Hemostaseolog, Salzburg, Austria
[2] Paracelsus Med Univ Salzburg, Dept Pathol, Salzburg, Austria
来源：
HAEMATOLOGICA | 2014年 / 99卷 / 05期
基金：
奥地利科学基金会;
关键词：
chronic lymphocytic leukemia; lenalidomide; T cell imhibitory receptors; CLL; DYSFUNCTION; MECHANISMS; DISEASE;
D O I：
10.3324/haematol.2013.098459
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E67 / E69
页数：3
相关论文
共 15 条
  • [1] Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+T Cells Is Linked to Antigen Recognition and T Cell Differentiation
    Bengsch, Bertram
    Seigel, Bianca
    Ruhl, Marianne
    Timm, Joerg
    Kuntz, Martin
    Blum, Hubert E.
    Pircher, Hanspeter
    Thimme, Robert
    [J]. PLOS PATHOGENS, 2010, 6 (06)
  • [2] The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia
    Brusa, Davide
    Serra, Sara
    Coscia, Marta
    Rossi, Davide
    D'Arena, Giovanni
    Laurenti, Luca
    Jaksic, Ozren
    Fedele, Giorgio
    Inghirami, Giorgio
    Gaidano, Gianluca
    Malavasi, Fabio
    Deaglio, Silvia
    [J]. HAEMATOLOGICA, 2013, 98 (06) : 953 - 963
  • [3] Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals
    Chidrawar, S.
    Khan, N.
    Wei, W.
    McLarnon, A.
    Smith, N.
    Nayak, L.
    Moss, P.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 155 (03) : 423 - 432
  • [4] A Combination of Fludarabine/Rituximab with Escalating Doses of Lenalidomide in Previously Untreated Chronic Lymphocytic Leukemia (CLL): The REVLIRIT CLL5 AGMT Phase I/II Study, Clinical and Exploratory Analyses of Induction Results
    Egle, Alexander
    Steurer, Michael
    Gassner, Franz
    Geisberger, Roland
    Melchardt, Thomas
    Weiss, Lukas
    Fridrik, Michael A.
    Thaler, Josef
    Lang, Alois
    Greil, Richard
    [J]. BLOOD, 2011, 118 (21) : 135 - 136
  • [5] Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia
    Gassner, Franz Josef
    Weiss, Lukas
    Geisberger, Roland
    Hofbauer, Josefina Pinon
    Egle, Alexander
    Hartmann, Tanja Nicole
    Greil, Richard
    Tinhofer, Inge
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (01) : 75 - 85
  • [6] The immunodeficiency of chronic lymphocytic leukaemia
    Hamblin, A. D.
    Hamblin, T. J.
    [J]. BRITISH MEDICAL BULLETIN, 2008, 87 (01) : 49 - 62
  • [7] Expansion of a CD8+PD-1+ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression
    Nunes, Claudia
    Wong, Ryan
    Mason, Malcolm
    Fegan, Chris
    Man, Stephen
    Pepper, Chris
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (03) : 678 - 687
  • [8] Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction
    Palmer, BE
    Blyveis, N
    Fontenot, AP
    Wilson, CC
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (12) : 8415 - 8423
  • [9] CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
    Parry, RV
    Chemnitz, JM
    Frauwirth, KA
    Lanfranco, AR
    Braunstein, I
    Kobayashi, SV
    Linsley, PS
    Thompson, CB
    Riley, JL
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (21) : 9543 - 9553
  • [10] Molecular and cellular mechanisms of CLL: novel therapeutic approaches
    Pleyer, Lisa
    Egle, Alexander
    Hartmann, Tanja Nicole
    Greil, Richard
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (07) : 405 - 418
12